Peerapat Technology Valuation
Is PRAPAT-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PRAPAT-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PRAPAT-R (THB1.88) is trading below our estimate of fair value (THB2.27)
Significantly Below Fair Value: PRAPAT-R is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PRAPAT-R?
Other financial metrics that can be useful for relative valuation.
What is PRAPAT-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿750.69m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1x |
Enterprise Value/EBITDA | 6x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does PRAPAT-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 12.8x | ||
COLOR Salee Colour | 19.7x | n/a | ฿718.5m |
EASON Eason & Co | 6.2x | n/a | ฿714.1m |
PMTA PM Thoresen Asia Holdings | 8.4x | n/a | ฿850.1m |
SUTHA Golden Lime | 16.9x | n/a | ฿1.1b |
PRAPAT-R Peerapat Technology | 13.2x | n/a | ฿731.2m |
Price-To-Earnings vs Peers: PRAPAT-R is expensive based on its Price-To-Earnings Ratio (13.2x) compared to the peer average (12.8x).
Price to Earnings Ratio vs Industry
How does PRAPAT-R's PE Ratio compare vs other companies in the TH Chemicals Industry?
Price-To-Earnings vs Industry: PRAPAT-R is good value based on its Price-To-Earnings Ratio (13.2x) compared to the TH Chemicals industry average (14.2x).
Price to Earnings Ratio vs Fair Ratio
What is PRAPAT-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PRAPAT-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.